Rehabilitation Techniques on Survivors of Acute Respiratory Distress Syndrome

NCT02787720 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2016-06-01

No results posted yet for this study

Summary

A randomized controlled blinded study in patients treated for Acute Respiratory Distress Syndrome (ARDS) in the mixed medical-surgical intensive care units (ICU) of four academic teaching hospitals in Tehran, Iran were conducted to examine the effects of Varied Rehabilitation Techniques on Survivors of ARDS patients. Patients were randomized in the emergency department at the time of ICU admission to one of four groups labeled groups 1, 2, 3 and 4, respectively.

Conditions

  • Acute Respiratory Distress Syndrome
  • Tobacco; Use, Rehabilitation

Interventions

OTHER

Family centered empowerment model

The intervention was conducting Family-Centered Empowerment Model. The intervention package had three steps including pre intervention, during intervention and post intervention. The model has four stages including Perceived threat, Problem solving, Educational partnership, and Evaluation

OTHER

Continuous care model

The intervention was conducting Family-Centered Empowerment Model. The intervention package had three steps including pre intervention, during intervention and post intervention. The model has four stages including Orientation, Sensitization, Control, and Evaluation

Sponsors & Collaborators

  • Shahid Beheshti University

    collaborator OTHER
  • Tehran University of Medical Sciences

    collaborator OTHER
  • Baqiyatallah Medical Sciences University

    lead OTHER

Principal Investigators

  • Amir Vahedian-azimi, Postdoc · Baqiyatallah Universiy of Medical Sciences

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-12-31
Primary Completion
2014-10-31
Completion
2014-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02787720 on ClinicalTrials.gov